Eagle Pharmaceuticals Extends Stockholder Rights Plan to October 2027

Eagle Pharmaceuticals extended its limited-duration stockholder rights plan by one year, through Oct. 30, 2027. The plan triggers at 10% ownership, or 15% for certain passive institutions.